Australia
· Delayed Price · Currency is AUD Neuren Pharmaceuticals Statistics
Total Valuation
ASX:NEU has a market cap or net worth of AUD 2.49 billion. The enterprise value is 2.19 billion.
| Market Cap | 2.49B |
| Enterprise Value | 2.19B |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:NEU has 126.29 million shares outstanding. The number of shares has decreased by -0.98% in one year.
| Current Share Class | 126.29M |
| Shares Outstanding | 126.29M |
| Shares Change (YoY) | -0.98% |
| Shares Change (QoQ) | -1.34% |
| Owned by Insiders (%) | 3.92% |
| Owned by Institutions (%) | 20.54% |
| Float | 108.92M |
Valuation Ratios
The trailing PE ratio is 17.16 and the forward PE ratio is 71.30.
| PE Ratio | 17.16 |
| Forward PE | 71.30 |
| PS Ratio | 11.37 |
| PB Ratio | 7.70 |
| P/TBV Ratio | 7.70 |
| P/FCF Ratio | 18.09 |
| P/OCF Ratio | 18.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.89, with an EV/FCF ratio of 15.91.
| EV / Earnings | 14.68 |
| EV / Sales | 10.00 |
| EV / EBITDA | 11.89 |
| EV / EBIT | 11.89 |
| EV / FCF | 15.91 |
Financial Position
The company has a current ratio of 40.42
| Current Ratio | 40.42 |
| Quick Ratio | 40.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 54.96% and return on invested capital (ROIC) is 42.42%.
| Return on Equity (ROE) | 54.96% |
| Return on Assets (ROA) | 41.13% |
| Return on Invested Capital (ROIC) | 42.42% |
| Return on Capital Employed (ROCE) | 56.93% |
| Revenue Per Employee | 27.36M |
| Profits Per Employee | 18.63M |
| Employee Count | 8 |
| Asset Turnover | 0.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:NEU has paid 41.76 million in taxes.
| Income Tax | 41.76M |
| Effective Tax Rate | 21.88% |
Stock Price Statistics
The stock price has increased by +29.01% in the last 52 weeks. The beta is 1.75, so ASX:NEU's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | +29.01% |
| 50-Day Moving Average | 18.26 |
| 200-Day Moving Average | 14.11 |
| Relative Strength Index (RSI) | 55.94 |
| Average Volume (20 Days) | 655,601 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:NEU had revenue of AUD 218.86 million and earned 149.06 million in profits. Earnings per share was 1.15.
| Revenue | 218.86M |
| Gross Profit | 188.88M |
| Operating Income | 184.07M |
| Pretax Income | 190.82M |
| Net Income | 149.06M |
| EBITDA | 184.10M |
| EBIT | 184.07M |
| Earnings Per Share (EPS) | 1.15 |
Balance Sheet
The company has 299.54 million in cash and n/a in debt, giving a net cash position of 299.54 million or 2.37 per share.
| Cash & Cash Equivalents | 299.54M |
| Total Debt | n/a |
| Net Cash | 299.54M |
| Net Cash Per Share | 2.37 |
| Equity (Book Value) | 323.27M |
| Book Value Per Share | 2.60 |
| Working Capital | 312.32M |
Cash Flow
In the last 12 months, operating cash flow was 137.57 million and capital expenditures -12,000, giving a free cash flow of 137.56 million.
| Operating Cash Flow | 137.57M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | 137.56M |
| FCF Per Share | 1.09 |
Margins
Gross margin is 86.30%, with operating and profit margins of 84.11% and 68.11%.
| Gross Margin | 86.30% |
| Operating Margin | 84.11% |
| Pretax Margin | 87.19% |
| Profit Margin | 68.11% |
| EBITDA Margin | 84.12% |
| EBIT Margin | 84.11% |
| FCF Margin | 62.85% |
Dividends & Yields
ASX:NEU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.98% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.99% |
| FCF Yield | 5.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 21, 2017. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 21, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ASX:NEU has an Altman Z-Score of 136.87 and a Piotroski F-Score of 5.
| Altman Z-Score | 136.87 |
| Piotroski F-Score | 5 |